{"id":"https://genegraph.clinicalgenome.org/r/19c1595c-514e-487e-a87f-52d56a807d3fv1.0","type":"EvidenceStrengthAssertion","dc:description":"SLC26A2 was first associated with autosomal recessive achondrogenesis type 1B as early as 1996 (Superti-Furga et al., PMID: 8528239). This disorder is perinatal lethal and includes clinical features such as extremely short limbs, fingers, and toes; hypoplasia of the thorax, protuberant abdomen, fetal hydrops, flat face, and a short and thick neck (GeneReviews, BonafÃ© et al., 2013). However, radiographic analysis and histopathology are also important in arriving at a diagnosis. At least 8 unique variants (including missense, nonsense, and frameshift variants as well as in-frame indels) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 8 probands in 3 publications (PMID: 8528239, 9637425, 8702490). More evidence is available in the literature; however, the maximum score for genetic evidence has been reached. Of note, variants in this gene have also been shown to cause atelosteogenesis type 2, diastrophic dysplasia, and recessive multiple epiphyseal dysplasia, which comprise a spectrum of phenotypes (depending on level of residual sulfate transport) and have been definitively associated with SLC26A2. This gene-disease association is supported by a knock-out mouse model, expression studies, and in vitro functional assays. In summary, SLC26A2 is definitively associated with autosomal recessive achondrogenesis type 1B. This curation was approved by the Skeletal Disorders Gene Curation Expert Panel (GCEP) on 8/3/2020.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/19c1595c-514e-487e-a87f-52d56a807d3f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2020-08-03T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2020-10-26T17:26:26.356Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b8a55b8-d732-4536-8c51-6066df1eee93_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This proband was awarded the default score due to functional evidence supporting the pathogenicity of the p.Val341del variant (Karniski et al. 2004, PMID: 15294877).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b483a94d-4c72-43b8-a746-821871957602","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":34,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008094","obo:HP_0009826","obo:HP_0012368","obo:HP_0003811","obo:HP_0009115","obo:HP_0001591","obo:HP_0001156"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1b8a55b8-d732-4536-8c51-6066df1eee93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1011_1013TGT[3] (p.Val341del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259846"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3a210bfb-4a40-4b35-af4e-602ea0f05fc7_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b65f8e2-cbea-49d5-96a9-d8822d51d3b0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 3","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":19,"detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3a210bfb-4a40-4b35-af4e-602ea0f05fc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":[{"id":"https://genegraph.clinicalgenome.org/r/f6999f97-8c36-4ba4-9e6f-4cc49ce2c06c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.451del (p.Tyr151fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274352"}},{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.532C>T (p.Arg178Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259839"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5a25a298-f8cc-4b56-9fc4-18c1b8e72f2d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The p.Asn425Asp varaitn was awarded 0.5 points due to functional evidence (Karniski et al. 2001, PMID: 11448940).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28f40e33-1f19-4733-8a7c-4c1c6ad2f149","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 6","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":31,"detectionMethod":"","firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5a25a298-f8cc-4b56-9fc4-18c1b8e72f2d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":[{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1724del (p.Lys575fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252988"}},{"id":"https://genegraph.clinicalgenome.org/r/04feeafa-ce43-4ccb-aeec-4fd02f8d35e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1273A>G (p.Asn425Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259842"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/028adcf1-ab74-4e62-9aa3-4714a8a4ee70_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This proband was awarded the default score due to functional evidence for the p.Leu483Pro variant (Karniski et al. 2001, PMID: 11448940).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb8e54e3-89d0-457c-b657-42ed3ec070bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","rdfs:label":"Rossi et al. proband","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":16,"detectionMethod":"","phenotypes":["obo:HP_0002983","obo:HP_0003026","obo:HP_0000773","obo:HP_0000256","obo:HP_0002866","obo:HP_0004599"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/028adcf1-ab74-4e62-9aa3-4714a8a4ee70_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f7b5656-7d99-4f89-8667-6623c2e79194","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1448T>C (p.Leu483Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA361707892"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9f386ef0-24ba-4abb-a283-52c8b03d1b19_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This proband was awarded the default score due to functional evidence supporting the pathogenicity of the p.Val341del variant (Karniski et al. 2004, PMID: 15294877).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32ff509b-1251-49f9-a485-1feac47377d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 2","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":37,"detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f386ef0-24ba-4abb-a283-52c8b03d1b19_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/200da69e-8d33-48a9-b743-c7b17d4e90c8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The p.Gly678Val variant was awarded 0.5 points due to functional evidence (Karniski et al. 2004, PMID: 15294877).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c863f6e-8166-4bf6-8b0a-1115342a1049","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 4","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":19,"detectionMethod":"","firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/200da69e-8d33-48a9-b743-c7b17d4e90c8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},{"id":"https://genegraph.clinicalgenome.org/r/6a0982c5-053c-4316-a165-df7d289b31fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.2033G>T (p.Gly678Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259844"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0b6c6082-05b5-4a55-888d-3ff7e2878300_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4470ec95-40b2-41e9-bd40-55bfe243ebdf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Patient 5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0b6c6082-05b5-4a55-888d-3ff7e2878300_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a6afec49-27e4-442c-a87c-a41a4717b98d"},{"id":"https://genegraph.clinicalgenome.org/r/f83d8d35-6f16-46ee-9a7e-b53cd5c9935c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.1194del (p.Ser399HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532190"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2fc3dc01-a675-4665-a876-993e3757f198_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This proband was awarded the default score due to functional evidence supporting the pathogenicity of the pl.Val341del variant (Karniski et al. 2004, PMID: 15294877).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/047af9a6-b114-4a84-98b7-121b9a03445f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9637425","rdfs:label":"Cai et al. proband","ageType":"AgeAtReport","ageUnit":"Weeks","ageValue":17,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000946","obo:HP_0001789","obo:HP_0001552","obo:HP_0008479","obo:HP_0008873","obo:HP_0003270","obo:HP_0000773","obo:HP_0009815","obo:HP_0000887","obo:HP_0003097","obo:HP_0000883","obo:HP_0006603","obo:HP_0009116","obo:HP_0002992","obo:HP_0031095"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2fc3dc01-a675-4665-a876-993e3757f198_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9637425","allele":{"id":"https://genegraph.clinicalgenome.org/r/27bf6fb9-e4cb-46f3-88fc-a2581286ac2d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc16120e-25ec-471a-92fa-66d57a69cef0","type":"EvidenceLine","dc:description":"The EP decided to downgrade this model to 1 point because while it was a complete knockout, it did not completely recapitulate the human phenotype (for example, accelerated ossification of vertebral bodies was inconsistent with ACG1B).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bad42e7-51e4-4933-9af1-821581991615","type":"Finding","dc:description":"Features such as short and thick neck, small chest, short limbs, protuberant abdomen, hypoplasia of the long bones, and short ribs are consistent with the presentation of ACG1B in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30685387","rdfs:label":"Knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94d34959-c289-4a74-b900-fb9fe9805636","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2568a151-61f4-426e-8a31-2801788ed332","type":"FunctionalAlteration","dc:description":"In chondrocytes from an ACG1B patient (homozygous for p.L483P), both large and small proteoglycans were undersulfated compared to controls.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8702490","rdfs:label":"Proteoglycan sulfation in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9fe8bcee-3e46-4df2-9ea0-353fa46c864d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa61ab94-3fdc-4bd0-91df-0053fae2a510","type":"FunctionalAlteration","dc:description":"Rate of sulfate incorporation in fibroblasts from ACG1B probands (patients 1, 2, 3, and 6 described in this paper) was <6% of controls.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8528239","rdfs:label":"Sulfate incorporation in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df420c99-8d73-473a-ae85-f3c4336260c7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c535a17e-cc18-4f1a-9969-7f6426d2141f","type":"Finding","dc:description":"Decreased uptake of extracellular sulfate has been demonstrated to be a mechanism for variants associated with ACG1B and other disorders of the SLC26A2 spectrum (PMID: 15294877).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9575183","rdfs:label":"Sulfate uptake assay","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4b72361d-ed11-4e43-9787-246d8d5c65fd","type":"EvidenceLine","dc:description":"In situ hybridization and immunostaining detected SLC26A2 mRNA in developing fetal hyaline cartilage and adult bronchial cartilage.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44571909-eefb-4c97-bb68-856675077c6e","type":"Finding","dc:description":"In situ hybridization and immunostaining detected SLC26A2 mRNA in developing fetal hyaline cartilage and adult bronchial cartilage.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11457925","rdfs:label":"Expression in cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/320f6198-9a2d-409a-8ee1-0c14fdd0647a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19ce88f9-c948-4450-98b7-a64fa9cb2741","type":"Finding","dc:description":"In situ hybridization showed that Slc26a2 was expressed in the limbs, craniofacial regions, and lumbosacral spine of mouse embryos at day 14.5.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26077908","rdfs:label":"Expression in mouse limbs, skull and spine","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/75f0f980-0a7d-4a68-9bc0-5bf8e9bade6b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36652c0d-e3d1-42c6-b3bc-378eb224dbbb","type":"Finding","dc:description":"Immunohistochemistry showed that Slc26a2 was expressed in the chondrocytes of freshly isolated mouse articular cartilage explants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25373420","rdfs:label":"Expression in mouse articular cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":1383,"specifiedBy":"GeneValidityCriteria7","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ecIhfd26Npo","type":"GeneValidityProposition","disease":"obo:MONDO_0010966","gene":"hgnc:10994","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_392a7ac1-7ef5-45c7-97e0-2c1c1bd7884d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}